Newton Biocapital

Europe. Europe Legal Chronicle. August 27, 2021

NeuVasQ Biotechnologies’ €20 Million Series A Investment Round

By Federica Tiefenthaler

Strelia advised Newton Biocapital on the deal. Newton Biocapital acted as lead investor in the 20 million series A investment round in NeuVasQ Biotechnologies, a spin-off of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Zenflow’s $24 Million Series C Financing Round

Tex-Tech Industries’ $165 Million Acquisition of Fiber Materials

Outbuild’s $11 Million Series A Financing Round

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

YPF Luz’s US$420 Million Notes Issuance

Sixth Street’s Joint Venture with Copley Point

First Camp Group’s Bonds Offering

BIT ODD’s €17 Million Equity Round

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

China Water Affairs Group Limited’s HK$361 Million Exchangeable Bonds Offering

APT Electronics’ Hong Kong IPO

Afcons Infrastructure’s $645 Million IPO

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

NeuVasQ Biotechnologies’ €20 Million Series A Investment Round

Standard 1 Year Membership Required